Physicians'assessments of the utility of health states associated with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) Infection.
An understanding of quality of life (QOL) with human immunodeficiency virus (HIV) is important because the merits of prevention and treatment alternatives may depend substantially on how these interventions affect QOL.
Physicians'views about QOL are important, because they influence the therapeutic options that physicians consider or offer, the recommendations that physicians make, and because they are important for the analysis of certain policy questions.
We assessed physicians'utilities of health states associated with HIV infection, and hepatitis B virus (HBV) infection ; assessment of utilities for HBV was included to provide a comparison with HIV utilities.
We surveyed 200 housestaff and staff physicians in an academic medical centre by anonymous paper-based questionnaire and used the time-tradeoff method to assess physicians'utilities of the health states.
On a scale in which 0 was equivalent to death, and 1 was equivalent to good health, the median utilities for asymptomatic HIV infection, symptomatic HIV infection, and AIDS were 0.833,0.417, and 0.167, respectively (p<0.01 for each two-way comparison).
Median utilities for asymptomatic HBV infection, mildly symptomatic HBV infection, and severely symptomatic HBV infection were 0.917,0.667, and 0.167, respectively (p<0.01 for each two-way comparison). (...)
Mots-clés Pascal : Analyse avantage coût, Maladie, Qualité vie, SIDA, Immunopathologie
Mots-clés Pascal anglais : Cost benefit analysis, Disease, Quality of life, AIDS, Immunopathology
Notice produite par :
ORS Auvergne - Observatoire Régional de la Santé d'Auvergne
Code Inist : 002B30A11. Création : 16/10/1997.